Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-23T00:55:03.446Z Has data issue: false hasContentIssue false
  • English
  • Français

Drug response patterns as a basis of nosology for the mood-incongruent psychoses (the schizophrenias)

Published online by Cambridge University Press:  09 July 2009

David L. Garver ,
Kathleen Kelly ,
Karen A. Fried ,
Mary Magnusson  and
Jack Hirschowitz
David L. Garver*
Affiliation:
Department of Psychiatry and Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
Kathleen Kelly
Affiliation:
Department of Psychiatry and Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
Karen A. Fried
Affiliation:
Department of Psychiatry and Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
Mary Magnusson
Affiliation:
Department of Psychiatry and Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
Jack Hirschowitz
Affiliation:
Department of Psychiatry and Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
*
1 Address for correspondence: Dr David L. Garver, Department of Psychiatry, University of Cincinnati College of Medicine, 231 Bethesda Avenue, Cincinnati, OH 45267–0559, USA.
Get access Rights & Permissions [Opens in a new window]

Synopsis

Interaction of therapeutic drugs with a series of different biopathological substrates of psychosis might be expected to generate a series of different response patterns. Herein the authors suggest that multi-modal response patterns following lithium and neuroleptic treatment of psychotic patients may aid in resolving the heterogeneity of psychotic disorders and lead to a new nosology of the psychoses.

Type
Research Article
Information
Psychological Medicine , Volume 18 , Issue 4 , November 1988 , pp. 873 - 885
Copyright
Copyright © Cambridge University Press 1988

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association, (1980). Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III). American Psychiatric Association Press: Washington D.C.Google Scholar
Andreasen, N. C. (1987). The diagnosis of schizophrenia. Schizophrenia Bulletin, National Institute of Mental Health 13, 9–22.Google ScholarPubMed
Andreasen, N. C.Olsen, S. A., Dennert, J. W. & Smith, M. R. (1982). Ventricular enlargement in schizophrenia: Relationship to positive and negative symptoms. American Journal of Psychiatry 134, 297–302.Google Scholar
Astrachan, B. M., Harrow, M., Adler, D., Brauer, L., Schwartz, A., Schwartz, C. & Tucker, G. (1972). A checklist for the diagnosis of schizophrenia. British Journal of Psychiatry 121, 529–539.CrossRefGoogle ScholarPubMed
Beasley, C., Magnusson, M. & Garver, D. L. (1987). Growth hormone response and neuroleptic response. Proceedings of the American Psychiatric Association 140, NR 94.Google Scholar
Beasley, C., Magnusson, M. & Garver, D. L. (1988). TSH response to TRH and differential drug response in psychoses. Biological Psychiatry, 24, 423–431.CrossRefGoogle Scholar
Bhattacharya, C. G. (1967). A simple method of resolution of a distribution into Gaussian components. Biometrics 23, 115–137.CrossRefGoogle ScholarPubMed
Bowers, M. B., Heninger, G. R. & Steinberg, D. E. (1983). Correlates of lithium response in psychotic-affective syndromes. Comprehensive Psychiatry 24, 469–474.CrossRefGoogle ScholarPubMed
Bowers, M. B., Swigas, M. E., Jatlow, P. I., Hoffman, F. J. & Goicoechea, N. (1987). Early neuroleptic response: clinical profiles and plasma catecholamine metabolites. Journal of Clinical Psychopharmacology 7, 83–86.CrossRefGoogle ScholarPubMed
Cornblatt, B. A. & Erlenmeyer-Kimling, L. (1985). Global attentional deviance as a marker of risk for schizophrenia: Specificity and predictive validity. Journal of Abnormal Psychology 94, 470–486.CrossRefGoogle ScholarPubMed
Crow, T. J. (1980). Molecular pathology of schizophrenia: more than one disease process? British Medical Journal 280, 66–68.CrossRefGoogle ScholarPubMed
Edelstein, P., Schultz, J. R., Hirschowitz, J., Kanter, D. R. & Garver, D. L. (1981). Physostigmine and lithium response in the schizophrenias. American Journal of Psychiatry 138, 1078–1081.Google ScholarPubMed
Endicott, J. (1978). SADS Summary Scale Scores, Third Edition. New York State Psychiatric Institute: New York.Google Scholar
Endicott, J. & Spitzer, R. L. (1978). A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia (SADS). Archives of General Psychiatry 35, 837–884.CrossRefGoogle Scholar
Garver, D. L., Hirschowitz, J., Fleischman, R. & Djuric, P. E. (1984). Lithium response and psychoses: A double-blind placebo controlled study. Psychiatry Research 12, 57–68.CrossRefGoogle ScholarPubMed
Garver, D. L., Sautter, F. J., Magnusson, M., Zemlan, F. P., Mavroidis, M. L. & Sanberg, P. R. (1987). Heterogeneity of neuroleptic response in psychosis. Proceedings of the American Psychiatric Association 140, 240.Google Scholar
Hitzemann, R., Mark, C., Hirschowitz, J. & Garver, D. L. (1985). Characteristics of phopholipid methylation in human erythrocyte ghosts: Relationship(s) to the psychoses and affective disorders. Biological Psychiatry 20, 397–407.CrossRefGoogle Scholar
Holtzman, P. S. (1987). Recent studies of psychophysiology in schizophrenia. Schizophrenia Bulletin 13, 49–75.CrossRefGoogle Scholar
Johnson, C. L., Johnson, C. G. & Garver, D. L. (1988). Phosphatidyl inositol signal transduction mechanisms in platelets from psychotic patients. (In preparation.)Google Scholar
Kanof, P. D., Johns, C., Davidson, M., Siever, L. J., Coccaro, E. F. & Davis, K. L. (1986). Prostaglandin receptor sensitivity in psychiatric disorders. Archives of General Psychiatry 43, 987–993.CrossRefGoogle ScholarPubMed
Kendler, K. S. & Gruenberg, A. M. (1984). An independent analysis of the Danish Adoption Study of Schizophrenia. IV. The relationship between psychiatric disorders as defined by DSM-III in the relatives and adoptees. Archives of General Psychiatry 41, 555–564.CrossRefGoogle Scholar
McCabe, M. S., Fowler, R. C., Cadoret, R. J. & Winokur, G. (1971). Familial differences in schizophrenia with good and poor prognosis. Psychological Medicine 1, 326–332.CrossRefGoogle ScholarPubMed
Mavroidis, M. L., Kanter, D. R., Hirschowitz, J. & Garver, D. L (1983). Clinical response and plasma haloperidol levels in schizophrenia. Psychopharmacology 81, 345–356.CrossRefGoogle ScholarPubMed
Sautter, F. & Garver, D. L. (1985). Familial differences in lithium responsive vs. lithium non-responsive psychoses. Journal of Psychiatric Research 19, 1–8.CrossRefGoogle Scholar
VanKammen, V. P. & Antelman, S. (1984). Mini-review: Impaired noradrenergic transmission in schizophrenia. Life Science 34, 1403–1413.CrossRefGoogle Scholar
Williams, A. O., Reveley, M. A., Kolakowska, T., Ardern, M. & Mandelbrote, B. M. (1985). Schizophrenia with good and poor outcome. II. Cerebral ventricular size and its clinical significance. British Journal of Psychiatry 146, 239–246.CrossRefGoogle ScholarPubMed
Zemlan, F. P., Hirschowitz, J., Sautter, F. J. & Garver, D. L. (1984). Impact of lithium therapy on core psychotic symptoms. British Journal of Psychiatry 144, 64–69.CrossRefGoogle Scholar